Evidence map›Paper›PMID 30198565›Full record

Trial reportBritish journal of haematology2019

Plasma metabolomics analysis in sickle cell disease patients with albuminuria - an exploratory study.

Laila Elsherif, Wimal Pathmasiri, Susan McRitchie, David R Archer, Kenneth I Ataga

Abstract readClinical TrialLetter
PubMed Full text at PMC Publisher
In one paragraph

Trial report in British journal of haematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laila ElsherifDepartment of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA.ORCID 0000-0002-6088-0332
Wimal PathmasiriNIH Common Fund Eastern Regional Comprehensive Metabolomics Resource Core, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Susan McRitchieNIH Common Fund Eastern Regional Comprehensive Metabolomics Resource Core, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
David R ArcherDepartment of Pediatrics, Emory University, Atlanta, GA, USA.ORCID 0000-0002-9185-0865
Kenneth I AtagaCenter for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, TN, USA.

Funding

RTI's Regional Comprehensive Metabolomics Resource CenterU24DK097193 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUMNER, SUSAN J · 2012 to 2017
$9.8M
Endothelial Dysfunction in the Pathogenesis of Sickle Cell NephropathyR01HL111659 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ARCHER, DAVID R, ATAGA, KENNETH I · 2012 to 2016
$2.3M
THE ASSOCIATION OF BIOMARKERS OF ENDOTHELIAL FUNCTION WITH PROSPECTIVE CHANGES IN KIDNEY FUNCTION IN SICKLE CELL ANEMIAR01FD006030 · FDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ATAGA, KENNETH I · 2017 to 2021
$2.0M
FDA HHS R01 FD006030NHLBI NIH HHS R01 HL111659NIDDK NIH HHS U24 DK097193
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MetabolomicsAdultAlbuminuriaAnemia, Sickle CellFemaleHumansMaleMiddle Agedalbuminuriachronic kidney diseaseglomerulopathymetabolomicsSickle cell anaemia

Identifiers

PMID30198565
PMCPMC6409098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.